偶然发现胶质瘤的现代外科管理
本文综述了偶然发现低级别胶质瘤(iLGG)的组织学标准、诊断影像、手术进展、切除与生存结局的相关性及临床意义;指出多项研究支持安全最大范围切除,但最佳治疗策略仍未明确,并强调此类肿瘤并非良性、需未来研究评估手术切除后的生存结局。
要点
- 偶然发现低级别胶质瘤(iLGG)的治疗策略仍有争议。
- 多项研究支持对iLGG行安全的最大范围切除。
- iLGG并非良性,需未来研究评估切除后生存结局。
核心结论
- 交替研究提示这些肿瘤的突变率可能高于对应级别的非偶然发现胶质瘤。
- 尽管多项研究支持安全最大范围切除,新诊断iLGG的最佳治疗策略仍未明确。
- 本综述强调偶然发现低级别胶质瘤并非良性,并进一步支持需未来研究评估手术切除后的生存结局。
研究设计与样本
- 本文为文献综述,作者设定了五个焦点子主题:组织学标准、诊断影像、手术进展、手术切除与生存结局的相关性及临床意义。
主要发现
- 交替研究提示这些肿瘤的突变率可能高于对应级别的非偶然发现胶质瘤。
- 现代神经外科治疗模式、诊断神经影像以及对肿瘤基因组成的更好理解,已在各级别胶质瘤的管理中取得显著进展。
- 多项研究支持对iLGG行安全最大范围切除,但新诊断iLGG的最佳治疗策略仍未明确。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Gliomas are the most common primary tumors of the central nervous system and are categorized by the World Health Organization into either low-grade (grades 1 and 2) or high-grade (grades 3 and 4) gliomas. A subset of patients with glioma may experience no tumor-related symptoms and be incidentally diagnosed. These incidental low-grade gliomas (iLGG) maintain controversial treatment course despite scientific advancements. Here we highlight the recent advancements in classification, neuroimaging, and surgical management of these tumors. METHODS: A review of the literature was performed. The authors created five subtopics of focus: histological criteria, diagnostic imaging, surgical advancements, correlation of surgical resection and survival outcomes, and clinical implications. CONCLUSIONS: Alternating studies suggest that these tumors may experience higher mutational rates than their counterparts. Significant progress in management of gliomas, regardless of the grade, has been made through modern neurosurgical treatment modalities, diagnostic neuroimaging, and a better understanding of the genetic composition of these tumors. An optimal treatment approach for patients with newly diagnosed iLGG remains ill-defined despite multiple studies arguing in favor of safe maximal resection. Our review emphasizes the not so benign nature of incidental low grade glioma and further supports the need for future studies to evaluate survival outcomes following surgical resection.
引用
- Pradhan A, Mozaffari K, Ghodrati F, et al. Modern surgical management of incidental gliomas. J Neurooncol. 2022. PMID: 35704158. doi:10.1007/s11060-022-04045-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。